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Insulin-like growth factor-1 (IGF-1) has been shown to play a
key role during embryonic and postnatal development of the
CNS, but its effect on a sensory organ has not been studied in
vivo. Therefore, we examined cochlear growth, differentiation,
and maturation in Igf-1 gene knock-out mice at postnatal days
5 (P5), P8, and P20 by using stereological methods and immu-
nohistochemistry. Mutant mice showed reduction in size of the
cochlea and cochlear ganglion. An immature tectorial mem-
brane and a significant decrease in the number and size of
auditory neurons were also evident at P20. IGF-1-deficient
cochlear neurons showed increased caspase-3-mediated ap-
optosis, along with aberrant expression of the early neural
markers nestin and Islet 1/2. Cochlear ganglion and fibers
innervating the sensory cells of the organ of Corti presented
decreased levels of neurofilament and myelin P0 in P20 mouse
mutants. In addition, an abnormal synaptophysin expression in
the somata of cochlear ganglion neurons and sensory hair cells
suggested the persistence of an immature pattern of synapses
distribution in the organ of Corti of these animals. These results
demonstrate that lack of IGF-1 in mice severely affects post-
natal survival, differentiation, and maturation of the cochlear
ganglion cells and causes abnormal innervation of the sensory
cells in the organ of Corti.
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Insulin-like growth factor-I (IGF-1), a 70 amino acid protein
structurally related to insulin, has pleiotropic effects during brain
embryonic and postnatal development (D’Ercole et al., 1996).
IGF-1 and its membrane receptor are expressed in the developing
nervous system in many areas related to projection neurons
during axon growth and synaptogenesis. IGF-1 expression peaks
in the mouse nervous system during the first two postnatal weeks
and then declines gradually to low adult levels (Bondy, 1991).
Studies disrupting the IGF-1 gene or IGF-type 1 high-affinity
receptor confirmed the essential role of IGF-1 in brain develop-
ment and maturation. IGF-1-deficient animals have severe
growth deficiency, generalized organ hypoplasia, and diminished
survival (Baker et al., 1993; Liu et al., 1993; Powell-Braxton et al.,
1993; Liu et al., 1998; Wang et al., 1999a). Their CNS phenotype
includes reduced brain size, hypomyelination, reduced axonal
diameters, and loss of selective neuronal populations (Beck et al.,
1995; Cheng et al., 1998; Gao et al., 1999). Conversely, transgenic
animals overexpressing IGF-1 have increased body and organ
weight, and their brains are abnormal, primarily because of in-
creased myelin (Carson et al., 1993; Ye et al., 1995; O’Kusky et
al., 2000). A detailed study focused on the impact of IGF-1 deficit
on a sensory organ is, however, still lacking.
In vitro studies have strongly suggested that IGF-1 is required
for chicken inner ear organogenesis (Leo´n et al., 1995, 1999; Sanz
et al., 1999a,b). IGF-1 is also expressed during maturation of the
rat auditory system and in adult hair cells (Lee and Cotanche,
1996; Saffer et al., 1996). IGF-1 displays neuroprotective activity
(Dore et al., 1997) and, in the rodent inner ear, IGF-1 increases
hair cell regeneration (Oesterle et al., 1997; Staecker and Van de
Water, 1998). In addition, a single case of a natural mutation of
the Igf-1 gene in a human showed growth failure and severe
sensorineural deafness (Woods et al., 1996, 1997).
The inner ear is a complex sensory organ responsible for sound
detection in vertebrates. The mechanosensory transduction in the
organ of Corti (OC) involves the interaction of specialized sen-
sory hair cells with the tectorial membrane. The cochlear gan-
glion contains the primary neurons that innervate the sensory
epithelia of the OC via afferent dendrites and transduce electro-
chemical output to the brainstem. Reciprocally, efferent axonal
fibers from the olivocochlear system innervate sensory cells (Berg-
lund and Ryugo, 1987; Spoendlin, 1988). The onset and tuning of
hearing depend on the correct relationship between the tectorial
membrane and the hair cells and the proper innervation and
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synaptogenesis of the sensory epithelium (Romand et al., 1987;
Rueda et al., 1996; Mu et al., 1997). Maturation of the cochlea
during the first two postnatal weeks in rodents involves cellular
differentiation and a massive rearrangement of afferent and ef-
ferent innervation (Rubel, 1978; Knipper et al., 1995).
Here we have studied whether IGF-1 participates in murine
postnatal cochlear development and maturation. We found that
mice lacking IGF-1 had a significant reduction in the size of the
cochlea and cochlear ganglion, an immature tectorial membrane,
a decrease in the number and size of auditory neurons, and a
general delayed maturation in the innervation of the OC.
MATERIALS AND METHODS
Mice and genotyping. Heterozygous mice with a targeted disruption of the
Ig f-1 gene were kindly provided by Dr. Argiris Efstratiadis at Columbia
University (New York, NY) (Liu et al., 1993). Animals were bred and
maintained on a hybrid genetic background of MF1 and 129/sv mouse
strains to increase nullizygous Ig f-1 mutant survival (Liu et al., 1993).
Heterozygous Ig f-1 mice (Ig f-1/) were bred to generate litters with
wild-type Ig f-1 (Ig f-1/), Ig f-1/ and Ig f-1/ progeny. The majority of
null animals do not survive until adulthood, considering the mortality
before postnatal day 20 (P20) is 80%. We focused our study on normal
Ig f-1/ and homozygous mutants Ig f-1/ animals at P5, P8, and P20.
Heterozygous mice were also studied, although they presented a highly
variable phenotype and, therefore, these results are not routinely pre-
sented. For genotyping by Southern blot analysis, DNA was prepared
from the tail tip following standard protocols (Hogan et al., 1994), and
probed as previously described (Liu et al., 1993). All animal handling
followed approved institutional protocols.
Fixation and histology. Mice were anesthetized with CO2 on dry ice
(P5) or by intraperitoneal injection of 0.12 mg/gm ketamine hydrochlo-
ride (P20) and perfused transcardially with 4% paraformaldehyde in 0.1
M PBS. Heads were removed and processed for celloidin or paraffin
embedding. For celloidin embedding, after removing skull vaults, heads
were post-fixed for 3 d in the same fixative, decalcified in 0.3 M EDTA,
pH 6.3, for 3 d (P5) or 7 d (P20) at room temperature, dehydrated in
ethanol for 7 d, and defatted in ether for 3 d. Specimens were cut along
the sagittal line and sequentially infiltrated in 2, 4, 6, and 12% low-
viscosity nitrocellulose (Celloidin; Fluka, Buchs, Switzerland) dissolved
in a 1:1 mixture of ethanol and ether. Celloidin blocks containing the
hemicrania were prepared from fresh 12% solution hardened with chlo-
roform vapors. Blocks were serially cut in 50-m-thick sections using a
sliding microtome, following different planes of section for each side: left
hemicrania were sectioned along the sagittal plane and right hemicrania
along the horizontal plane. Sections were collected and stored in 70%
ethanol. For stereological observations, every second section was
mounted and Nissl-stained using 1% cresyl violet. For some histological
studies, additional thinner (25 m) celloidin sections were used. For
paraffin embedding, temporal bones containing the inner ear were re-
moved, post-fixed in buffered 4% paraformaldehyde for 2 d, decalcified in
0.3 M EDTA, pH 6.3, dehydrated in ethanol, and embedded in paraffin.
Serial 10 m sagittal sections were used for TUNEL labeling or immu-
nohistochemical studies. At least four animals of each genotype were
sampled for each assay.
Stereolog ical analysis and statistics. Celloidin sections were used to
obtain quantitative data on morphological parameters of the cochlea. We
estimated the total volume of the cochlea and cochlear ganglion, the
cochlear ganglion total neuron number, and the mean soma volume of
ganglion neurons. No correction for shrinkage was introduced. All mea-
surements were performed using an interactive computer system consist-
ing of a high-precision motorized microscope stage, a 0.5 m resolution
z-axis reader (microcator Heidenhain VZR 401), a solid-state video
camera, and a high-resolution video monitor. The objectives used were a
planachromatic X20 (Splan 20; Olympus, Hamburg, Germany) and a
planapochromatic 100 oil immersion lens with a numerical aperture of
1.4 (S-Plan Apo 100; Olympus). The interactive test grids and control of
the motorized stage were provided by the GRID general stereological
software package (Olympus) running on an Amiga 2000 computer.
Every second celloidin section of the whole structure that contained
the entire cochlea or the cochlear ganglion was selected for measuring
their respective volumes (10 sections per inner ear). An unbiased
estimate of the total volume ( V) of the cochlea, including the otic
capsule, was obtained by point-counting using a uniform point grid,
applying the principle of Cavalieri (Gundersen et al., 1988; Blasco et al.,
1999). Following this principle, V  t  a(p)   Pi, where t is the mean
distance between two sections (t  0.1 mm), a(p) is the area associated
to each test point [a (p)  0.002028 mm 2], and Pi is the number of points
that fall within the cochlea on each section. The cochlear ganglion
volume was estimated applying the same method and considering “gan-
glionar area” all groups of neurons with more than two juxtaposed
neuron bodies.
The absolute number of neurons (N), the mean cell body volume, and
the distribution of individual volumes were obtained simultaneously in
each cochlear ganglion, by means of the optical fractionator (Gundersen
et al., 1988; West et al., 1991), which is a stereological development that
combines the optical disector with a fractionator sampling scheme and
the vertical planar rotator (Jensen and Gundersen, 1993; Tandrup et al.,
1997; Lagares and Avendan˜o, 2000).
The method used for obtaining the absolute neuron number ( N)
consisted in counting the cell nuclei that appeared within a series of
systematically random-sampled volumes (Q-) and dividing it by the
fraction of the total volume of the ganglion represented by the addition
of the sampled volumes ( fT), N  (Q
-)  1/fT. The fractionator
sampling scheme was applied as follows: (1) every second section was
used for counting ( fS  1/2); (2) the cochlear ganglion was divided into
fixed areas, the first of which was positioned at random; a stepping motor
moved the microscope stage systematically to other locations at pre-
established and fixed distances. The area of the disector frame covered
352 m 2, which was a fraction ( fd) of the total sampled area ( fd  1/10).
Finally, (3) the disector height was set at 20 m, so the fraction of the
total section thickness sampled was fh  20/t. The mean section thickness
for each ganglion was estimated from the microcator readings of three or
four measurements per section, performed by focusing from top to
bottom surfaces of the tissue. The average t for all ganglia was 48.7 m.
The total sampling fraction is the product of the fractions at each step of
the sampling procedure, fT  fS  fd  fh. The optical disector (Sterio,
1984) was applied in each sampled field.
Neuronal nuclei were selected on the basis of cellular pyknosis, nu-
cleus shape, and defined presence of nucleolus. Cells without a well-
defined nuclear membrane and at least one nucleolus were excluded. All
nuclei whose equator came into focus 10 m below the section surface
and within the disector frame were counted, as were other nuclei coming
into focus as the focal plane was lowered up to 30 m below the surface.
Nuclei touching the lowest plane, or either of two predetermined adja-
cent sides of the rectangular disector frame, were not included in the
count. The perikaryal volume of the same ganglion cells that were
sampled for obtaining N was estimated by means of the vertical planar
rotator (Jensen and Gundersen 1993; Avendan˜o and Dykes, 1996). This
procedure consists of positioning a grid of parallel and equidistant lines
orthogonal to a “vertical” axis drawn through the nucleolus and parallel
to the cutting direction. Because of the spiral course of the ganglion, the
cell bodies revolve around the vertical axis. This effectively substitutes
the use of various orientations of the cutting planes around the vertical
axis, a requisite to guarantee isotropy in measuring designs that use
“vertical” sections (Gundersen et al., 1988). The rotator allows estima-
tion of the mean cell volume of the entire population (VN), as well as
plotting a distribution of neurons on the basis of body size (West, 1999).
The precision of the estimations was evaluated by computing the coef-
ficient of error as described for systematic random samples (Howard and
Reed, 1998; Gundersen et al., 1988; Blasco et al., 1999). With this
sampling scheme the coefficient of error was 5% for cochlear and
ganglion volume estimations and 12% for cell number. Individual mean
volume estimates were computed for each ganglion. Cell volume distri-
butions were computed for each size by dividing individual measure-
ments into eight classes using both linear and logarithmic-converted
scales. The population percentage of cells belonging to each class volume
was calculated as the average of the percentage of cells belonging to that
class in different mice. Student’s t test was used to assess significance of
the data on volume and number of cells of the cochlea and cochlear
ganglion. The Kruskal–Wallis test was applied to data on perikaryal
volume.
Terminal deoxynucleotidyl transferase-mediated UTP nick end labeling,
4	,6	-diamidino-2-phenylindole, and propidium iodide staining. Terminal
deoxynucleotidyl transferase-mediated UTP nick end labeling (TUNEL)
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was performed following manufacturer’s instructions (Roche Diagnos-
tics, Mannheim, Germany), adapted to paraffin sections. Briefly, depar-
affinized sections were permeated in 20 g/ml of proteinase K, for 15
min at 37°C. Endogenous peroxidase was inhibited by treatment with
3.0% H2O2 (Sigma, St. Louis, MO) in methanol. Sections were then
incubated with the terminal deoxynucleotidyl transferase enzyme diluted
1:20 (v/v) in the terminal deoxynucleotidyl-transferase buffer containing
biotin-16-deoxy-UTP, for 1 hr at 37°C. Unspecific binding was then
blocked by treatment with 3% BSA (Sigma) for 30 min. TUNEL signal
was visualized with an antibody coupled to peroxidase (Converted-Pod,
1:5 dilution; Roche Diagnostics), for 30 min at 37°C. Signal development
was performed with 0.5 mg/ml diaminobenzidine tetrahydrochloride
(Sigma) and 0.01% H2O2 and observed with an Olympus M021 light
microscope. For 4	,6	-diamidino-2-phenylindole (DAPI) staining, paraf-
fin sections were mounted using 4 g/ml DAPI (Sigma) to visualize
pyknotic nuclei. Alternatively, sections were stained with propidium
iodide (10 g/ml) (Sigma) and observed with a Zeiss Axioscope fluo-
rescence microscope or an MCR 1924 confocal microscope (Bio-Rad,
Hemel Hempstead, Hertfordshire, UK).
Immunohistochemistry. Paraffin sections (10 m) of temporal bones
from at least four Ig f-1/ and Ig f-1/ mice were used. After deparaf-
fination and rehydration in PBS, sections were incubated with a blocking
solution of 0.1% Triton X-100 in PBS, containing either 1% BSA or 10%
sheep serum. Samples were quenched in 0.6–1.5% H2O2 and left over-
night at 4°C in blocking solution containing different primary antibodies.
Sources, dilution, and cell specificity of the antibodies used in this study
were: anti-proliferative cell nuclear antigen (PCNA) mouse monoclonal
(Concepta, Barcelona, Spain) (1:500); anti-caspase-3 activated mouse
polyclonal (Srinivasan et al., 1998) (1:100); anti-Islet 1/2, mouse mono-
clonal (Developmental Studies Hybridoma Bank) (1:200); anti-Nestin
128, rabbit polyclonal (Lendahl et al., 1990) (1:500); anti-Neurofilament
200 kDa, mouse monoclonal (Diagnostic, Mannheim, Germany) (1:50);
anti-synaptophysin, rabbit polyclonal (Dako, Copenhagen, Denmark)
Figure 1. Cochlear anatomy of the mouse ge-
notypes analyzed and IGF-1 expression. Nissl
staining of mid-modiolar celloidin sections of
the cochlea at P5 (A, B) or P20 (C, D) in
Igf-1/ (A, C) and Igf-1/ (B, D) mice. An
increased thickness of the otic capsule cartilage
and a dispersion of the fibers in the auditory
branch of the eighth cranial nerve of Igf-1/
at P5 (star) were observed in all animals stud-
ied. Note the reduction in size of Igf-1/ P20
cochlea compared with the Igf-1/ P20 con-
trols. IGF-1 immunohistochemical expression
in the cochlea (E) and cochlear ganglia (F)
of P20 Igf-1/ mice. Asterisk in E indicates the
area shown in F; arrowheads in F point to
the subpopulation of IGF-1-positive neurons.
The inset shows a magnification of the cochlear
ganglion of Igf-1/ P20 animals (G). C, Co-
chlear duct; O, otic capsule; OC, organ of
Corti; CG, cochlear ganglion; VIII, eighth cra-
nial nerve; TM, tectorial membrane; SL, spiral
limbus; SV, stria vascularis. Scale bars: A–D,
650 m; E, 600 m; F, 55 m; G, 10 m.
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(1:100); anti-GFAP, rabbit polyclonal (Dako) (1:100); anti-Myelin P0,
mouse monoclonal (Cao et al., 1996) (1:500); and anti-vimentin VIM3B4
mouse monoclonal (Colucci-Guyon et al., 1994) (Profer Immuno-
Diagnostika, Heidelberg, Germany) (1:100). These molecules are mark-
ers for proliferative cells, apoptotic cells, young neurons, precursor cells,
neurons, synapses, glial cells, myelin and immature neurons, respectively.
Anti-IGF-I rabbit polyclonal UB3–189 (1:100) was from National Pitu-
itary Agency (Baltimore, MD). After incubation with EnVision anti-
mouse or anti-rabbit peroxidase-conjugated secondary antibodies (Dako,
Copenhagen, Denmark) for 30 min, peroxidase was reacted with 0.66
Figure 2. Altered morphology of the OC tec-
torial membrane in Igf-1/ P20 mice. Nissl
staining of celloidin-embedded cross sections
of the OC of P20 Igf-1/ (A, C) and Igf-1/
(B, D) animals. A and B show basal turns,
whereas C and D show apical turns of the
cochlea. Physical attachment of the tectorial
membrane to the hair cells was noticed in all
sections of P20 Igf-1/ (B, D, arrows). BM,
Basilar membrane; DC, Deiters’ cells; IHC, in-
ner hair cells; OHC, outer hair cells; TM, tec-
torial membrane. Scale bars, 30 m.
Table 1. Body weight and cochlear volume
Mouse number Age Body weight (gm) Igf-1 genotype
Mean cochlear
volume (mm3)
1 P5 3.9 / 1.10
2 P5 2.8 / 1.68
3 P5 2.9 / 1.30
Mean P5 Igf-1/ 3.2 
 0.6 1.36 
 0.30
4 P5 1.4 / 1.39
5 P5 1.7 / 1.32
6 P5 1.6 / 1.00
Mean P5 Igf-1/ 1.6 
 0.2a 1.24 
 0.21b
7 P20 11.5 / 2.21
8 P20 11.8 / 2.07
9 P20 10.9 / 2.03
10 P20 10.2 / 2.37
11 P20 9.5 / 1.99
Mean P20 Igf-1/ 10.8 
 0.9 2.13 
 0.16
12 P20 5.2 / 1.56
13 P20 4.0 / 1.53
14 P20 3.7 / 1.33
15 P20 5.1 / 1.19
16 P20 5.4 / 1.42
Mean P20 Igf-1/ 4.7 
 0.7c,d 1.41 
 0.15c,d
Values are expressed as mean 
 SD. The total volume of the cochlea includes the otic capsule. Mean values of the two
cochleas per animal are presented. Data were obtained by applying the stereological principle of Cavalieri to point-counts
obtained using a uniform grid, as described in Materials and Methods. Statistical analysis was performed using Student’s t
test.
aDifference from P5 Igf-1/; p  0.05.
bNot significantly different from P5 Igf-1/.
cDifference from P20 Igf-1/; p  0.001.
dDifference from P5 Igf-1/; p  0.001.
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mg/ml diaminobenzidine tetrahydrochloride (DAB) (Sigma) and 0.02%
H2O2 (Sigma).
RESULTS
IGF-1 is required for normal postnatal development of
cochlear structures
To assess the effect of IGF-1 deficiency on the general morphol-
ogy of the cochlea, we examined serial inner ear sections of
normal Igf-1/ and mutant Igf-1/ mice at P5 and P20 (Fig. 1).
P5 Igf-1/ animals showed a thicker cartilaginous otic capsule
and a more disperse distribution of the fibers from the auditory
branch of the eighth cranial nerve than the normal littermates
(Fig. 1A,B). At P20, mutant cochleas displayed no major alter-
ation in general gross anatomy, but a significant reduction in size
was evident (Fig. 1D) when compared with normal mice (Fig.
1C). Figure 1, E and F, shows positive immunolabel for IGF-1 in
the cochlea and cochlear ganglion of normal mice at P20. IGF-1
is strongly expressed in a subpopulation of neurons of the co-
chlear ganglion. Other structures in the cochlea, such as stria
vascularis, spiral limbus, and support cells of the OC, pre-
sented also IGF-1 staining. A similar expression pattern was
observed at P5 (data not shown). The lack of expression of
IGF-1 in the cochlear neurons of null mice is shown in the inset
(Fig. 1G) and is compared with positive wild-type neurons (Fig.
1F, arrowheads).
The most typical phenotypic characteristic of the Igf-1 null
mutation is general growth retardation (Liu et al., 1993; Baker et
al., 1993; Powell-Braxton et al., 1993). Therefore, the volume of
the cochlea was calculated by a quantitative stereological analysis
(Table 1). The body weight of Igf-1/ animals used in this study
was reduced between 50 (P5) and 60% (P20) relative to that of
the Igf-1/ littermates, as previously published (Baker et al.,
1993). In contrast, Igf-1/ mice showed a nonsignificant reduc-
tion 9% in cochlear volume at P5 when compared with Igf-1/
but a very significant 34% reduction (compare 1.41 
 0.15 with
2.13 
 0.16 mm3) at P20 (Table 1, Fig. 1). This suggests that
Figure 3. Altered cochlear ganglion mor-
phology in Igf-1/ mice. Nissl staining of
the ganglion in the cochlear basal turn in
Igf-1/ (A, C) and Igf-1/ (B, D) mice at
P5 (A, B) and P20 (C, D). At P5, the co-
chlear ganglion and its neurons show simi-
lar morphology in both genotypes (arrow-
heads), except that Igf-1/ mouse also
show a subtype of abnormally small,
strongly chromaffinic cells (open arrow). At
P20, ganglion cells are noticeably reduced
both in size and number in Igf-1/ mice.
This reduction, despite the presence of en-
larged intercellular spaces (arrows), leads
to a considerable decrease in the ganglion
cross-sectional area. E and F show negative
PCNA expression in the cochlear ganglion
cells of P5 Igf-1/ (E) and Igf-1/ (F)
mice. The inset (G) shows a positive control
of PCNA-positive cerebellum cells from
the same section of P20 Igf-1/ mouse
shown in F. Scale bar, 30 m.
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growth retardation in the cochlea was less marked and appeared
later than the whole body dwarfism.
A detailed analysis of Igf-1/ cochleas evidenced additional
morphological alterations when compared with normal Igf-1/
controls (Fig. 2). The anchorage of the tectorial membrane to the
sensory hair cells of the OC in mutant P20 mice is altered with
respect to normal mice. During early postnatal development of
the mouse inner ear, the tectorial membrane remains firmly
attached to the sensory epithelium until the marginal pillars, a
glycoprotein structure secreted by Deiters’ cells, disappear
around P14. It is also by the end of the second postnatal week
when the mouse cochlear microarchitecture is considered fully
developed and ready for normal auditory function (Rueda et al.,
1996). Microscopic examination of the P20 inner ear from Igf-
1/ mice indicated that in all sections, analyzed from the base to
the apex, of the cochlea (20 sections from each of the five animals
studied), the tectorial membrane remained physically attached to
the underlying OC, by a membrane-like structure that may be a
remnant of marginal pillars (Fig. 2B,D). Attachment was also
observed in mice of both genotypes at P5, in accordance with
their immature state (data not shown). The OC was normal, as
judged from the morphological studies performed (Fig. 2). These
results indicate that the absence of IGF-1 causes a delay in
cochlear development at the level of tectorial membrane
maturation.
Reduced total volume, neuronal cell loss, and
decreased neuronal cell size in the cochlear ganglion
of Igf-1/ mice
Multiple cellular abnormalities were observed in Igf-1/ co-
chleas at P5 and, more dramatic, at P20 stages. At P5, normal and
mutant ganglia presented similar size and cellular densities (Fig.
3A,B), although Igf-1/ mice showed a subtype of small cells,
with more intense chromatin Nissl staining and non-neuronal
appearance (Fig. 3B). At P20, when the sense of hearing is
completely functional, ganglia from Igf-1/ mice showed a se-
verely affected morphology compared with their Igf-1/ litter-
mates. The formers were reduced in size, with fewer neurons and
wider intercellular spaces (Fig. 3C,D). PCNA is a DNA-binding
protein required for progression through the S phase of the cell
cycle (Celis and Celis, 1985). Figure 3, E and F, shows absence of
PCNA expression indicating that cochlear neurons were postmi-
totic at P5 in both null and normal mice (Fig. 3E,F), whereas
cerebellar neurons were actively proliferating at the same age
(Fig. 3G).
To further characterize these phenotypic differences, we per-
formed measurements of the cochlear ganglion, as detailed in
Materials and Methods. The comparison of P5 Igf-1/ with
Igf-1/ ganglia revealed no significant differences in the three
parameters evaluated, ganglion volume, number of neurons, and
neuronal cell volume (Table 2). In P20 Igf-1/ mice, however, all
three morphological parameters presented significant reductions
with respect to normal mice: 27% in ganglion volume (0.035 vs
0.048 mm3), 22% in neuron number (13,400 vs 16,600; 3400
ganglion neurons were lost at P20 from an initial total calculated
of 16,800 in Igf-1/ at P5), and 31% in neuronal cell volume
(380 vs 547 m3). Comparison of P20 Igf-1/ with P5 ganglion
cells of either genotype did not show significant changes during
this time interval (Table 2). Data on Igf-1/ indicated a mod-
erate decrease in cochlear ganglion volume (10%) and in neuro-
nal size (12%).
Computerized treatment of the data obtained in the stereo-
logical analysis allowed us to study the distribution of the different
proportions of neuronal soma sizes. Figure 4 shows the ganglion
cellular distribution by cell volumes. By P5, Igf-1/ and Igf-1/
cochlear neurons showed identical proportions of the different
cell volumes represented, with most cells (80%) measuring
between 300 and 800 m3 (Fig. 4). Although the mean neuron
cell volume was 500 m3 (Table 2), the modal neuronal cell
volume was 425 m3. These data indicate that smaller cells
were present in higher proportions. At P20, the Igf-1/ cochlear
ganglion contained a similar distribution of neuronal soma sizes,
but with an increase in the proportion of cells with larger vol-
umes, as indicated by the increase of the mean cell volume to 547
m3 (Table 2). A new subclass of cells appeared with a volume
950 m3, which was not observed in P5 Igf-1/ mice (Fig. 4).
A logarithmic representation showed that neuronal volume dis-
tribution of the P20 Igf-1/ ganglion was almost symmetric
around the most abundant cell size value, 350–400 m3 (data not
Table 2. Comparison of ganglion volume, neuronal number, and neuronal soma volume of cochlear ganglia
Ganglion volumea (mm3)
Number of neuronsb
(in thousands) Neuronal somac volume (m3)
Mean % variationd Mean % variationd Mean % variationd
P5
Igf-1/ n  3 0.046 
 0.009 0 16.1 
 0.7 0 506
 42 0
Igf-1/ n  3 0.051 
 0.010 11 16.8 
 0.2 4 527
 23 4
P20
Igf-1/ n  5 0.048 
 0.003 4 16.6 
 0.6 3 547
 28 8
Igf-1/ n  3 0.043 
 0.003e 6 17.6 
 0.6 9 482
 29e 5
Igf-1/ n  5 0.035 
 0.003f,g 24 13.4 
 0.9f,g 17 380 
 15f,g 25
All data were obtained using stereological methods as described in Materials and Methods and are expressed as mean 
 SD.
aThe total volume of ganglia (mm 3 
 SD) represents regions occupied by neuronal cell bodies and excludes areas containing nerve fibers. Data were obtained applying the
principle of Cavalieri.
bThe number of neurons in the cochlear ganglion was estimated by means of the “optical fractionator.”
cNeuronal soma volume (m 3 
 SD) was obtained using the “rotator.”
dPercentual variation with respect to P5 Igf-1/.
eDiffers from P20 Igf-l/; p  0.05.
fDiffers from P20 Igf-1/; p  0.001.
gDiffers from P5 Igf-1/; p  0.005.
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shown; mean, 380 m3). This result reflects a significant reduc-
tion in the number of large ganglion neurons in P20 Igf-1/ mice
compared with their Igf-1/ littermates. The former did not
display cells larger than 800 m3, which represented 10% of the
ganglion neurons in normal animals. In contrast, 75% of the
Igf-1/ neurons were smaller than 400 m3, whereas in Igf-1/
animals they only represented 40%. Taken together, these data
demonstrate that the absence of IGF-1 during postnatal matura-
tion of the inner ear produces a decrease in the number of
cochlear ganglion neurons and reduces their mean soma volume.
To analyze whether neuronal cell loss was attributable to
apoptosis, we performed TUNEL labeling and activated
caspase-3 detection in Igf-1/ and Igf-1/ inner ear paraffin
sections at P5, P8, and P20. Normal Igf-1/ mice were negative
for apoptotic nuclei (Fig. 5A,E) and activated caspase-3 (Fig.
5B,F,J) across the ages studied (5, 8, and 20 d). In contrast, in the
Igf-1/ mice cochleas a significant number of cells were positive
with both TUNEL labeling (Fig. 5C,G,K) and anti-activated
caspase-3 immunostaining (Fig. 5D,H,L). Cells positive for ac-
tivated caspase-3 decreased in number from P5 to P20, which
indicates that most affected cells have disappeared at P20.
These data suggest that in the absence of IGF-1 cochlear
neurons suffer caspase-3-mediated cell death. The number of
apoptotic TUNEL-positive cells decreased from base to apex
at P5 and P8 but it increased at P20 (data not shown). Because
the structural maturation of the postnatal cochlea proceeds from
basal to apical regions, these data suggest that IGF-1 deficit
affects more the survival of cells at a more advanced stage of
maturation. In parallel, sections of the inner ear from Igf-1/
and Igf-1/ mice were stained with propidium iodide or DAPI.
P5 samples from both genotypes showed no differences, whereas
P20 Igf-1/, but not Igf-1/ ganglion cells presented strong
staining and nuclear anomalies (data not shown) that may be part
of the apoptotic program.
Delayed neural differentiation of postnatal Igf-1 null
cochlear ganglion
To further characterize the cellular abnormalities evidenced by
the stereological analysis in the Igf-1/ cochlea, a panel of
differentiation and maturation markers of neurons and glia was
tested by immunostaining of sections from normal and mutant
cochlear ganglia. Nestin, the intermediate filament characteristic
of progenitor cells, showed differential expression at stages P5 and
P20. At P5, there was no staining in normal Igf-1/ mice (Fig.
6A), but most Igf-1/ ganglion neurons showed intense expres-
sion (Fig. 6B). At P20, none of the genotypes expressed nestin in
ganglion neurons; however, nestin was detected in a population of
small non-neuronal cells in Igf-1/ animals (Fig. 6C), but not in
the mutants (Fig. 6D). The scattered pattern of nestin expression
detected in Igf-1/ ganglia may correspond to glial cell precur-
sors (Lendahl et al., 1990). The expression pattern of the tran-
scription factor Islet 1/2 in the cochlear ganglion of mutant mice
also points to delayed or failed maturation of PCNA-negative
postmitotic cells (Fig. 3E–H). Islet 1/2 was present at P5 in both
genotypes (Fig. 6E,F), but disappeared in normal P20 Igf-1/
mice (Fig. 6G). In contrast, P20 Igf-1/ ganglion neurons still
expressed this transcription factor (Fig. 6H).
Immunostaining of cochlear ganglion with synaptophysin evi-
denced expression of this synaptic marker in almost all neurons at
P5 and P20 in both genotypes (Fig. 6 I–L). However, the normal
P20 Igf-1/ showed a compact and localized synaptophysin
staining pattern, whereas in P20 Igf-1/ neurons the immuno-
labeled material covered most of the cell surface in a diffuse, less
mature pattern (Fig. 6L). This distinct pattern in the P20 mutant
ganglion may reflect altered synaptic refinement in the absence of
IGF-1 action. Neurofilament expression was observed at P5, with
no differences between genotypes, whereas at P20 Igf-1/ ani-
mals showed less staining than Igf-1/ littermates (data not
shown).
In most of the bipolar neurons of the postnatal vertebrate
cochlear nerve, myelin envelops the axon, the perikaryon, and the
dendrite (Toesca, 1996). Because previous studies have reported
altered myelination in Igf-1 mutant mice, we used myelin P0 and
GFAP antibodies to detect possible alterations in myelination and
Schwann cells. At P5, there were no differences in the expression
pattern of both markers between genotypes. Myelin P0 immuno-
reactivity surrounded most ganglion neurons (Fig. 6M,N), con-
firming previous data obtained in rats (Toesca, 1996; Knipper et
al., 1998), whereas GFAP was undetectable (Fig. 6Q,R). In con-
trast, at P20 the levels of both antigens were lower in the mutants
(Fig. 6P,T) than in the normal mice (Fig. 6O,S), indicating a
Figure 4. Different perikaryal volume distributions of cochlear ganglion
neurons in Igf-1/ and Igf-1/ mice. Linear plots of data obtained by
application of stereological methods (see Materials and Methods) are
represented for P5 (top) and P20 (bottom) mice. Error bars represent the
SD among animals for each volume class. Whereas the distribution is
monomodal in all cases, note the leftward displacement of the curve in the
mutant mice at P20, with a marked decrease of cells in the largest size
classes. See Table 2 for statistical analysis.
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deficit in myelination during postnatal cochlear ganglion devel-
opment of Igf-1/ mice.
Altered innervation, synaptogenesis, and myelination
in the sensory cells of the organ of Corti in Igf-1
mutant mice
The synaptogenesis and innervation of the OC sensory cells was
also altered in Igf-1/ animals (Fig. 7). In rats, anti-synapto-
physin antibody labels the synaptic vesicles of the efferent fibers
and follows a dynamic expression pattern as synaptic maturation
progresses beyond early postnatal stages (Knipper et al., 1995,
1996). In P5 mice, synaptophysin labeled nerve terminals with a
similar pattern in both genotypes (Fig. 7A,B). Positive synapto-
physin staining appeared with low intensity in nerve fibers from
the cochlear ganglion. Staining increased considerably as fibers
continue to innervate the base of the sensory cells, forming a
diffuse “cup-like” shape almost covering the basal half of the cell
bodies. The strongest but most diffuse staining was localized at
the base of the inner hair cells in Igf-1/ animals (Fig. 7A). As
synaptogenesis progresses, in P20 hair cells the area of synapto-
physin expression was reduced, remaining circumscribed to the
basal part of the sensory cells and to discrete points located more
distally from the base. In contrast, P20 Igf-1/ mice showed
stronger, less localized staining (Fig. 7C,D). In these mice, im-
munopositive presumptive nerve terminals appeared to project
synapses up to the supranuclear level of the inner and outer hair
cells, resembling the immature situation observed at P5. Neuro-
filament protein (NF-200 kDa) labeling of the bundle of fibers
between the cochlear ganglion and the sensory epithelium pre-
sented the same strong expression pattern in both genotypes at P5
(Fig. 7E,F). At P20, Igf-1/ fibers showed considerable neuro-
filament staining (Fig. 7G), which was notably reduced in Igf-
1/, indicating deficits in the density of innervation to the hair
cells (Fig. 7H), and correlating with the defective cochlear neu-
ron survival. The loss in cochlear ganglion neurons produced by
IGF-1 deficit also affected the cochlear nerve. In P20 normal mice
the nerve showed a continuous fiber-like distribution of neuro-
filament staining, whereas, on the contrary, P20 Igf-1/ animals
showed less neurofilament staining in a discontinuous patchy
distribution and increased levels of vimentin (data not shown).
Myelin P0 immunostaining of fibers projecting from the cochlear
ganglion to the sensory cells at P5 was similar in normal and
mutant animals (Fig. 7I,J), whereas the increase in expression in
P20 Igf-1/ cochleas (Fig. 7K) was not observed in the Igf-1/
counterparts (Fig. 7L). Taken together, these data show that the
differentiation and maturation of the entire cochlear innervation
system is affected by IGF-1 deficit.
DISCUSSION
The present study demonstrates that IGF-1 absence impairs nor-
mal postnatal development of mice cochlear structures. At the
whole organ level, we found that the cochleas of P5 Igf-1/ mice
were similar to those of Igf-1/. But, from P5 to P20, Igf-1/
cochlear volume increased by 14%, whereas normal mice cochlear
volume increased by 57%. Many, if not all, cochlear structures
appeared to be affected. This suggests that the absence of IGF-1
is compensated by alternative factors during embryonic and early
Figure 5. Apoptotic cell death in the cochlear ganglion of Igf-1/ mice. TUNEL labeling (A, C, E, G, K ) and detection of activated caspase-3
expression (B, D, F, H, J, L) were performed on paraffin sections from normal (Igf-1/) and mutant (Igf-1/) mice at postnatal days 5, 8, and 20. The
area analyzed is shown in a schematic drawing of the cochlea in which the square indicates basal turn cochlear ganglia ( I). Note the increase in apoptotic
nuclei (C, G, K ) and intense activated caspase-3 immunostaining (D, H, L) in the mutant mice. Arrowheads point to apoptotic neurons, whereas arrows
point to dying glial cells. The sections correspond to basal turns of the cochlea. Scale bar, 30 m.
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postnatal cochlear development, but cochlear growth is IGF-1-
dependent at later stages. Igf-1 nullizygous mice display postnatal
general growth retardation with organ-specific size alterations
(Liu et al., 1993). For example, adult brain is less affected by the
growth deficit (30%) than whole body (60%) (Cheng et al.,
1998). To our knowledge, no organ has been studied early enough
to know if there is normal growth before P5 as we report for the
cochlea (Powell-Braxton et al., 1993; Beck et al., 1995; Wang et
al., 1999a).
At the cellular level, the actions of IGF-1 appeared to be
diverse. Cochlear ganglia cellular content was reduced by 22%,
and the mean size of the sensory neurons of the cochlear ganglia
was also reduced in the knock-out mice at P20. Cochlear ganglion
neurons suffered a mean size reduction in the range of that
described for other cell types. Thus, chondrocytes from bone
growth plates and testicular Leydig Igf-1/ cells show size
reduction, attributed to their delayed developmental stage (Baker
et al., 1996; Wang et al., 1999b). Proliferating mutant uterine cells
also present a 20–40% decrease in cell size and augmented DNA
content, associated to slow progression through the cell cycle
Figure 6. Delayed differentiation of postnatal cochlear ganglion in Igf-1/ mice. Immunohistochemical analysis of paraffin sections of the cochlear
ganglion at midmodiolar levels using nestin (A–D), Islet-1/2 (E–H), synaptophysin ( I–L), myelin P0 (M–P), and GFAP (Q–T) antibodies. Left panels (A,
E, I, M, Q) correspond to P5 Igf-1/ samples, middle-lef t panels (B, F, J, N, R) to P5 Igf-1/, middle-right panels (C, G, K, O, S) are from P20 Igf-1/,
and right panels (D, H, L, P, T ) from P20 Igf-1/ mice. E–H correspond to basal turns of the cochlear ganglion, and the remaining sections in the figure
are from apical turns. Scale bars: A–L, 40 m; M–T, 30 m.
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(Adesanya et al., 1999). In a mirror image, IGF-1 P7 transgenic
mice present increased cell size in the hippocampal dentate gyrus
(O’Kusky et al., 2000). Cell size is regulated by a complex net of
transduction pathways (Conlon and Raff, 1999), where the par-
ticipation of an insulin/IGF receptor substrate has been shown
even in Drosophila, in which mutant cells were fewer and smaller
than normal (Bohni et al., 1999).
Transient IGF-1 gene expression has been reported during the
maturation of the mice auditory sensory relay system (Bondy,
1991). Here, we show the local expression of IGF-1 in cochlear
structures including a subpopulation of cochlear ganglion neu-
rons, stria vascularis, spiral limbus, and support cells of the OC.
Therefore, the alterations observed in inner ear structures may be
attributable to the local deficit of IGF-1 actions superimposed to
the lack of circulating IGF-1 (Trejo et al., 2001).
In our study, both mutant and normal cochlear ganglia have
similar numbers of postmitotic neurons at P5, but Igf-1/ mice
showed a considerable loss of ganglion neurons from P5 to P20, a
time frame in which IGF-1 action appears to be critical for
survival of cochlear neurons. This cell loss was attributable to
apoptosis accompanied by an increased number of neurons ex-
pressing activated caspase-3, a protease implicated in neural cell
death as deduced from the caspase-3 mutant mice that present
decreased apoptosis in the brain (Kuida et al., 1996). Apoptosis
caused by IGF-1 deficit was more intense in cells of the basal turn
of the cochlea, the more mature region, whose development
proceeds from base to apex (Mikaelian and Ruben, 1964). There-
fore, IGF-1 should be included in the list of previously described
trophic factors required for mouse auditory neurons survival
(Fekete, 1999; Bussoli and Steel, 2001), which all together must
cooperate postnatally in modulating the number of neurons in the
cochlear ganglion.
Our results also demonstrate that IGF-1 action is required for
timely differentiation and maturation of the cochlea. Two major
morphological alterations were observed in the P20 Igf-1 mutants.
The first was the presence of a thicker cartilaginous otic capsule
in the Igf-1/ cochlea, confirming studies that reported retarded
ossification (Baker et al., 1993). The second was a firmer anchor-
ing of the tectorial membrane to the OC by the abnormal perma-
nence of the marginal pillars, a transitory laminar structure that
disappears at P14 in normal mice. A fully functional tectorial
membrane is required for an appropriate gain and timing of
cochlear feedback (Legan et al., 2000). The immature perma-
nence of the marginal pillars in P20 limit relative mechanical
motion between the tectorial membrane and the hair cells, thus
creating higher thresholds than in the normal cochlea (Romand et
al., 1987; Rueda et al., 1996). Permanent attachment and severe
distortion of the tectorial membrane were reported in hypothy-
roid rats (Uziel et al., 1983; Prieto et al., 1990). Because it has
been reported that adult IGF-1 mutant animals might hear loud
noises (Cheng et al., 1998), the evaluation of the impact of the
abnormalities shown in the present study on frequency thresholds
will need future electrophysiological analysis.
A delayed developmental pattern was also observed in the
cochlear ganglia of IGF-1 deficient mouse. Differentiation of
Igf-1/ cochlea was evaluated with the markers nestin and
Figure 7. Differential expression of neural and glial markers in the innervation of the organ of Corti. Immunohistochemical staining of midmodiolar
paraffin sections of basal turns of the cochlea with synaptophysin (A–D), neurofilament 200 kDa (E–H), and myelin P0 ( I–L) antibodies. Left panels (A,
E, I ) correspond to P5 Igf-1/ samples, middle-lef t panels (B, F, J ) to P5 Igf-1/, middle-right panels (C, G, K ) to P20 Igf-1/, and right panels (D,
H, L) to P20 Igf-1/ mice. At P5 (A, B), synaptophysin immunoreactivity appears diffuse and displays a “cup-like” shape surrounding the IHCs
(arrowheads) and OHCs (arrows). At P20 (C, D), the synaptophysin staining pattern is better defined at the base of IHC and nerve fibers in the Igf-1/
controls than in Igf-1/ mutants. NF-200K and myelin P0 immunostainings do not evidence major differences at P5 but are clearly less intense in P20
Igf-1/ mice (H, L) than in Igf-1/ controls (G, K, arrow). Scale bars: A–D, 20 m; E–L, 30 m.
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Islet-1/2. Nestin is a marker for neural precursor cells (Lendahl et
al., 1990), whereas Islet transcription factors play important roles
in neuronal differentiation (Tsuchida et al., 1994). Cochlear gan-
glion cells are postmitotic but cells that have recently withdrawn
from the cell cycle can still be nestin positive (Vicario-Abejo´n et
al., 1995). Therefore, P5 Igf-1/ nestin-positive cells supported
the presence of neuroblasts, delayed in developmental stage com-
pared with P5 Igf-1/ counterparts. Altered Islet 1/2 expression
confirmed the delayed developmental pattern.
Our results indicate that absence of IGF-1 causes increased
apoptosis, a decrease in neuronal size, and abnormal neuronal
differentiation. Damage of cochlear ganglion neurons may be
deleterious to hair cells and vice versa (Ryan, 2000), leaving open
the possibility that the alterations described in Igf-1/ cochlear
neurons could lead to damage in hair cells. In fact, P20 Igf-1/
mutant animals maintained innervation to the cochlear sensory
cells, but their synapses were altered, either because of a delay in
differentiation or refining, or because they tried to compensate
the deficit of innervation because of neuronal loss. The cochlear
nerve showed a dispersed fiber phenotype in the center of the
cochlea, associated with decreased neurofilament protein expres-
sion in nerve fibers. Mice with mutations in neurofilament genes
have reduced axonal diameters, a phenotype previously described
in Igf-1 mutant nerves (Hirokawa, and Takeda, 1998; Gao et al.,
1999). Synaptophysin expression in normal cochlear ganglion and
OC was similar to that reported in the rat inner ear (Knipper et
al., 1995, 1996). The alterations observed in Igf-1/ cochlea
might reflect transient growth of immature synaptic processes.
Therefore, the local presence of IGF-1 would be required during
this critical period for neuronal connections. It has been reported
that a coordinated process of axonal growth and synaptogenesis
takes place at P9 in rodents, probably as a consequence of
competition for the sensory epithelium (Pujol, 1986). In the
dentate gyrus, IGF-1 overexpression produces increases in the
total number of synapses (O’Kusky et al., 2000), thus confirming
that IGF-1 supports synaptogenesis during mice postnatal
development.
Myelination in Igf-1/ cochlear fibers was also delayed or
altered, as reflected by the expression of myelination markers.
The myelination of the cochlear ganglia sensory neurons occurs
postnatally (Schwartz et al., 1983). At P20, The reduction in the
level of myelin P0 was dramatic. Previous studies on hypothyroid
rats also show decreased myelin P0 mRNA levels in the cochlear
ganglion and hair cell innervation (Knipper et al., 1998). Inter-
estingly, myelin protein P0 is an autoantigen in human autoim-
mune inner ear disease (Cao et al., 1996). The innervation of the
OC has been proposed as critical for neuronal survival and
postnatal development of cochlear sensitivity (Ernfors et al.,
1995; Bruce et al., 2000). These results are in agreement with
earlier studies on mice with a different Igf-1 targeted mutation,
showing that Igf-1 gene disruption produces loss of certain neu-
ronal subpopulations, a general decrease in axonal diameters,
selective hypomyelination, and reduced nerve conduction veloc-
ities in vivo (Beck et al., 1995; Cheng et al., 1998; Gao et al., 1999).
Furthermore, selective overexpression of IGF-1 in brain causes
an increase in neuron number, total brain myelin, and regional
density of myelinated axons (Behringer et al., 1990; Carson et al.,
1993; Ye et al., 1995).
In summary, we have shown that IGF-1-deficient mice had a
size reduction of the cochlea and cochlear ganglion, an immature
tectorial membrane, and a significant decrease in the number and
size of auditory neurons. Analysis of key markers demonstrated
that lack of IGF-1 produces a general delay in differentiation of
the cochlear ganglion cells during postnatal development. Co-
chlear ganglion fibers presented decreased myelination, abnormal
synaptogenesis, and deficient innervation of the sensory cells in
the OC. This cochlear phenotype provides basis to understand
one of the mechanisms leading to sensorineural deafness, as
found in the human patient with a homozygous Igf-1 gene dele-
tion (Woods et al., 1996, 1997). Our findings further support the
inclusion of IGF-1 among the essential neurotrophic factors to be
considered as molecules with potential therapeutic value.
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